03:54 PM EST - BELLUS Health Inc. : announced consummation of the previously announced strategic partnership between the two companies whereby Pharmascience will pay a total of $17.25 million to BELLUS Health, including $8.15 million in non-dilutive capital and a $9.1 million investment for a 10.4% ownership stake in a new public company. Shares will begin trading on a consolidated basis of one new post-consolidation common share for every 30 pre-consolidation common shares on the Toronto Stock Exchange under the ticker "BLU" at market open on May 29. BELLUS Health Inc.
shares T.BLU are trading down $0.005 at $0.04.
